DermaSensor’s device is a spectroscopy-based objective tool to help clinicians evaluate suspected lesions for some of the most common forms of skin cancer, including basal cell carcinoma ...

Was that mole always there? Photograph, track, and identify marks with these apps before you head to your dermatologist.

Its approval is based on a pivotal trial involving more than 1,000 patients, led by the Mayo Clinic, which found that the device had a sensitivity of 96% across all 224 skin cancer cases in the ...

One in five Americans will develop skin cancer by the age of 70. That’s why regular skin checks are important for early detection along with consulting a doctor if you notice any unusual lesions or ...

An artificial intelligence (AI)–enabled handheld elastic scattering spectroscopy (ESS) device improved the sensitivity for skin cancer diagnosis and management by primary care physicians (PCPs ...

Handheld devices, which a health-care ... The 2.0 version of this would entail bringing in AI to automatically detect skin cancer, she says. “We need a lot more research, ...

Introducing DermaSensor - America’s First Automated Skin Cancer Detection Device for Physicians. Legal Disclaimer: EIN Presswire provides this news content "as is" without warranty of any kind.

Skin cancer tech firm appoints C-suite executive, advisory board expand DermaSensor is the maker of a medical device that primary care physicians can use to detect skin cancer on patients.

Dr. Armand Cognetta assumed the practice launched by Dr. Stuart Smith, who opened the first independent dermatology practice ...

Skin cancer detection firm lands £15m to fund growth plans. ... Sky News has learnt that Skin Analytics, whose derm device has been shown to diagnose the disease with a 99.9% accuracy rate, ...

DermaSensor isn’t the only AI-based skin cancer detection device on the market. UK-based Skin Analytics’ DERM device captures dermoscopic images of skin lesions, which are then analysed by a ...

US-based DermaSensor has announced a newly published study showing that its AI-powered device can improve a primary care physician’s ability to assess moles of concern. In the prospective study ...